Stability of transmembrane amyloid ?-peptide and membrane integrity tested by molecular modeling of site-specific A?42 mutations.
Ontology highlight
ABSTRACT: Interactions of the amyloid ?-protein (A?) with neuronal cell membranes, leading to the disruption of membrane integrity, are considered to play a key role in the development of Alzheimer's disease. Natural mutations in A?42, such as the Arctic mutation (E22G) have been shown to increase A?42 aggregation and neurotoxicity, leading to the early-onset of Alzheimer's disease. A correlation between the propensity of A?42 to form protofibrils and its effect on neuronal dysfunction and degeneration has been established. Using rational mutagenesis of the A?42 peptide it was further revealed that the aggregation of different A?42 mutants in lipid membranes results in a variety of polymorphic aggregates in a mutation dependent manner. The mutant peptides also have a variable ability to disrupt bilayer integrity. To further test the connection between A?42 mutation and peptide-membrane interactions, we perform molecular dynamics simulations of membrane-inserted A?42 variants (wild-type and E22G, D23G, E22G/D23G, K16M/K28M and K16M/E22G/D23G/K28M mutants) as ?-sheet monomers and tetramers. The effects of charged residues on transmembrane A?42 stability and membrane integrity are analyzed at atomistic level. We observe an increased stability for the E22G A?42 peptide and a decreased stability for D23G compared to wild-type A?42, while D23G has the largest membrane-disruptive effect. These results support the experimental observation that the altered toxicity arising from mutations in A? is not only a result of the altered aggregation propensity, but also originates from modified A? interactions with neuronal membranes.
SUBMITTER: Poojari C
PROVIDER: S-EPMC3820573 | biostudies-literature | 2013
REPOSITORIES: biostudies-literature
ACCESS DATA